Skip to main content
Top
Published in: Pediatric Nephrology 8/2006

01-08-2006 | Original Article

Low protein Z levels in children with nephrotic syndrome

Authors: Ozan Özkaya, Kenan Bek, Tunc Fışgın, Yuksel Aliyazıcıoğlu, Sevinc Sultansuyu, Yonca Açıkgöz, Davut Albayrak, Kemal Baysal

Published in: Pediatric Nephrology | Issue 8/2006

Login to get access

Abstract

Acquired deficiency of anticoagulant proteins, due to loss in the urine, has been proposed as one of the major thrombogenic alterations in nephrotic syndrome (NS). Protein Z (PZ) is a single-chain vitamin K-dependent glycoprotein. Low PZ levels are reported to be a risk factor for thrombosis. The aim of this study was to investigate protein Z and other natural anticoagulant levels in children with NS. Thirty children aged between 1.5 and 12 years with NS (Groups I and II) and 19 age-and-sex-matched healthy controls (Group III) were enrolled into the study. Patients were divided into two groups: Group I (proteinuria >40 mg/m2/hr) and Group II (patients in remission). Plasma PZ levels in Group I were significantly lower than Group II (p=0.009) and group III (p=0.018). Plasma levels of AT III for Group I were significantly lower than for Groups II and III (p=0.009, p=0.005, respectively). Protein C levels in Group I were higher than in Group II and Group III (p=0.002, p=0.000, respectively). Protein Z levels positively correlated with serum total protein and albumin levels (p=0.003, p=0.003, respectively) and negatively with the degree of proteinuria (p=0.000). Protein Z levels were positively correlated with AT III (r=0.037, p=0.04). Along with the other coagulation abnormalities, decreased protein Z may contribute to increased risk of thromboembolic complications in children with NS. The negative correlation between proteinuria and PZ level suggests the possibility of renal PZ loss. Further studies are needed to investigate the mechanism and role of decreased PZ in NS.
Literature
1.
go back to reference Mehls O, Andrassy K, Koderisch J, Herzog U, Ritz E (1987) Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 110:862–867CrossRef Mehls O, Andrassy K, Koderisch J, Herzog U, Ritz E (1987) Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 110:862–867CrossRef
2.
go back to reference Harris RC, Ismail N (1994) Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 23:477–497CrossRef Harris RC, Ismail N (1994) Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 23:477–497CrossRef
3.
go back to reference Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 75:804–810CrossRef Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 75:804–810CrossRef
4.
go back to reference Özkayýn N, Mir S, Kavakli K (2004) Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity. Int Urol Nephrol 36:599–603CrossRef Özkayýn N, Mir S, Kavakli K (2004) Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity. Int Urol Nephrol 36:599–603CrossRef
5.
go back to reference Singhal R, Brimble KS (2005) Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res DOI: 10.1016/j.thromres.2005.03.030 Singhal R, Brimble KS (2005) Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res DOI: 10.1016/j.thromres.2005.03.030
6.
go back to reference Citak A, Emre S, Sairin A, Bilge I, Nayir A (2000) Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 14:138–142CrossRef Citak A, Emre S, Sairin A, Bilge I, Nayir A (2000) Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 14:138–142CrossRef
7.
go back to reference Han X, Fiehler R, Broze GJ Jr (2000) Characterization of the protein Z-dependent protease inhibitor. Blood 96:3049–3055CrossRef Han X, Fiehler R, Broze GJ Jr (2000) Characterization of the protein Z-dependent protease inhibitor. Blood 96:3049–3055CrossRef
8.
go back to reference Han X, Huang ZF, Fiehler R, Broze GJ Jr (1999) The protein Z-dependent protease inhibitor is a serpin. Biochemistry 24:11073–11078CrossRef Han X, Huang ZF, Fiehler R, Broze GJ Jr (1999) The protein Z-dependent protease inhibitor is a serpin. Biochemistry 24:11073–11078CrossRef
9.
go back to reference Kemkes-Matthes B, Matthes KJ (2001) Protein Z. Semin Thromb Hemost 27:551–556CrossRef Kemkes-Matthes B, Matthes KJ (2001) Protein Z. Semin Thromb Hemost 27:551–556CrossRef
10.
go back to reference Broze GJ Jr (2001) Protein Z-dependent regulation of coagulation. Thromb Haemost 86:8–13CrossRef Broze GJ Jr (2001) Protein Z-dependent regulation of coagulation. Thromb Haemost 86:8–13CrossRef
11.
go back to reference Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E, Rosendaal FR, Broze GJ Jr (2005) Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost 93:411–413CrossRef Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E, Rosendaal FR, Broze GJ Jr (2005) Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost 93:411–413CrossRef
12.
go back to reference Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C (2001) Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 24:933–944CrossRef Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C (2001) Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 24:933–944CrossRef
13.
go back to reference International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef
14.
go back to reference Tkaczyk M, Baj Z, Zbigniew (2002) Surface markers of platelet function in idiopathic nephritic syndrome in children. Pediatr Nephrol 17:673–677CrossRef Tkaczyk M, Baj Z, Zbigniew (2002) Surface markers of platelet function in idiopathic nephritic syndrome in children. Pediatr Nephrol 17:673–677CrossRef
15.
go back to reference Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A (2005) Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol 20:36–41CrossRef Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A (2005) Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol 20:36–41CrossRef
16.
go back to reference Hogg PJ, Stenflo J (1991) Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles. J Biol Chem 15:10953–10958 Hogg PJ, Stenflo J (1991) Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles. J Biol Chem 15:10953–10958
17.
go back to reference Kobelt K, Biasiutti FD, Mattle HP, Lammle B, Wuillemin WA (2001) Protein Z in ischaemic stroke. Br J Haematol 114:169–173 Kobelt K, Biasiutti FD, Mattle HP, Lammle B, Wuillemin WA (2001) Protein Z in ischaemic stroke. Br J Haematol 114:169–173
18.
go back to reference Malyszko J, Malyszko JS, Mysliwiec M (2002) Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 13:615–621CrossRef Malyszko J, Malyszko JS, Mysliwiec M (2002) Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 13:615–621CrossRef
19.
go back to reference al-Mugeiren MM, Gader AM, al-Rasheed SA, Bahakim HM, al-Momen AK, al-Salloum A (1996) Coagulopathy of childhood nephrotic syndrome-a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis 26:304–310PubMed al-Mugeiren MM, Gader AM, al-Rasheed SA, Bahakim HM, al-Momen AK, al-Salloum A (1996) Coagulopathy of childhood nephrotic syndrome-a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis 26:304–310PubMed
20.
go back to reference Llach F (1985) Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28:429–439CrossRef Llach F (1985) Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28:429–439CrossRef
21.
go back to reference Mannucci PM, Valsecchi C, Bottasso B, D’Angelo A, Casati S, Ponticelli C (1986) High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb Haemost 28:31–33 Mannucci PM, Valsecchi C, Bottasso B, D’Angelo A, Casati S, Ponticelli C (1986) High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb Haemost 28:31–33
Metadata
Title
Low protein Z levels in children with nephrotic syndrome
Authors
Ozan Özkaya
Kenan Bek
Tunc Fışgın
Yuksel Aliyazıcıoğlu
Sevinc Sultansuyu
Yonca Açıkgöz
Davut Albayrak
Kemal Baysal
Publication date
01-08-2006
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 8/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0167-6

Other articles of this Issue 8/2006

Pediatric Nephrology 8/2006 Go to the issue